These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 19434916)

  • 1. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease" [Bioorg. Med. Chem. Lett. 17 (2007) 1897-1902].
    Bioorg Med Chem Lett; 2009 Feb; 19(3):1035. PubMed ID: 19434916
    [No Abstract]   [Full Text] [Related]  

  • 2. Retraction notice to "Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats" [Bioorg. Med. Chem. 17 (2007) 15 (2007) 4903-4909].
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2009 Jan; 17(2):930. PubMed ID: 19177601
    [No Abstract]   [Full Text] [Related]  

  • 3. Retraction notice to "Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease" [European Journal of Medicinal Chemistry 42 (2006) 885-890].
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2008 Dec; 43(12):2909. PubMed ID: 19172758
    [No Abstract]   [Full Text] [Related]  

  • 4. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid with D-phenylalanine for colon specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Bhatt L; Vadnerkar G; Kadam SS
    Bioorg Med Chem Lett; 2007 Apr; 17(7):1897-902. PubMed ID: 17280832
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrug of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Kandpal M; Vadnerkar G; Rathi B; Kadam SS
    Eur J Med Chem; 2007 Jun; 42(6):885-90. PubMed ID: 17258353
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Synthesis, kinetic studies and pharmacological evaluation of mutual azo prodrugs of 5-aminosalicylic acid for colon-specific drug delivery in inflammatory bowel disease.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L; Rathi B; Kadam SS
    Eur J Med Chem; 2009 Oct; 44(10):3922-9. PubMed ID: 19442419
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Colon-specific, mutual azo prodrug of 5-aminosalicylic acid with L-tryptophan: synthesis, kinetic studies and evaluation of its mitigating effect in trinitrobenzenesulfonic acid-induced colitis in rats.
    Dhaneshwar SS; Gairola N; Kandpal M; Vadnerkar G; Bhatt L
    Bioorg Med Chem; 2007 Jul; 15(14):4903-9. PubMed ID: 17499512
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

  • 9. Retraction notice to "Synthesis and bioevaluation of aryl-guanidino polyamine conjugates targeting the polyamine transporter" [Bioorg. Med. Chem. Lett. 20 (2010) 6421-6425].
    Wang J; Chen Z; Xie S; Zhao J; Wang C
    Bioorg Med Chem Lett; 2021 Sep; 47():128251. PubMed ID: 34256984
    [No Abstract]   [Full Text] [Related]  

  • 10. 5-Aminosalicylic Acid Azo-Linked to Procainamide Acts as an Anticolitic Mutual Prodrug via Additive Inhibition of Nuclear Factor kappaB.
    Kim W; Nam J; Lee S; Jeong S; Jung Y
    Mol Pharm; 2016 Jun; 13(6):2126-35. PubMed ID: 27112518
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retraction notice to "Sannastatin, a novel toxic macrolactam polyketide glycoside produced by actinomycete Streptomyces sannanensis" [Bioorg. Med. Chem. Lett. 21 (2011) 3905-3908].
    Yang SX; Gao JM; Zhang AL; Laatsch H
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4219. PubMed ID: 28826506
    [No Abstract]   [Full Text] [Related]  

  • 12. Retraction notice to "Two novel bioactive glucosinolates from broccoli (Brassica oleracea L. var. italica) florets" [Bioorg. Med. Chem. Lett. 22 (2012) 5555-5558].
    Bioorg Med Chem Lett; 2013 Nov; 23(22):6201. PubMed ID: 24288810
    [No Abstract]   [Full Text] [Related]  

  • 13. Retraction notice to "A computational docking study for prediction of binding mode of diospyrin and derivatives: Inhibitors of human and leishmanial DNA topoisomerase-I" [Bioorg. Med. Chem. Lett. 17 (2007) 4604-4612].
    Bioorg Med Chem Lett; 2007 Sep; 17(18):5281. PubMed ID: 17987674
    [No Abstract]   [Full Text] [Related]  

  • 14. Retraction notice to "Preclinical metabolism of LB42908, a novel farnesyl transferase inhibitor, and its effects on the cytochrome P450 isozyme activities" [Bioorg. Med. Chem. Lett. 22(9) (2012) 3067-3071].
    Chang M; Lee SH; Kim HJ; Koh JS; Kim A
    Bioorg Med Chem Lett; 2024 May; 104():129734. PubMed ID: 38604924
    [No Abstract]   [Full Text] [Related]  

  • 15. Retraction notice to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis" [Bioorg. Med. Chem. 19 (2011) 5175-82].
    Bioorg Med Chem; 2015 Jan; 23(1):272. PubMed ID: 25671237
    [No Abstract]   [Full Text] [Related]  

  • 16. Retraction notice to 'Corrigendum to "3-Benzhydryl-4-piperidones as novel neurokinin-1 receptor antagonists and their efficient synthesis"' [Bioorg. Med. Chem. 20 (2012) 5668-5668].
    Bioorg Med Chem; 2014 Dec; 22(23):6726. PubMed ID: 25756091
    [No Abstract]   [Full Text] [Related]  

  • 17. Retraction notice to 'Design and synthesis of CHAP31, trapoxin B and HC-toxin based bicyclic tetrapeptides disulfide as potent histone deacetylase inhibitors' [Bioorg Med Chem 22 (2014) 3850-3855].
    Bioorg Med Chem; 2015 Aug; 23(15):5078. PubMed ID: 26425745
    [No Abstract]   [Full Text] [Related]  

  • 18. Synthesis, colon-targeted studies and pharmacological evaluation of an anti-ulcerative colitis drug 4-Aminosalicylic acid-β-O-glucoside.
    Li F; Wu G; Zheng H; Wang L; Zhao Z
    Eur J Med Chem; 2016 Jan; 108():486-494. PubMed ID: 26717200
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Corrigendum to "Synthesis and preliminary pharmacological evaluation of N-2-(4-(4-(2-substitutedthiazol-4-yl) piperazin-1-yl)-2-oxoethyl)acetamides as novel atypical antipsychotic agents" [Bioorg. Med. Chem. Lett. 18 (2008) 6054-6057].
    Sekhar KVGC; Rao VS; Devambatla RKV; Kumar MMK
    Bioorg Med Chem Lett; 2017 May; 27(9):2081. PubMed ID: 28336140
    [No Abstract]   [Full Text] [Related]  

  • 20. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.